Do you want to read an article? Please log in or register.
Ultrasound-Guided Radiofrequency Ablation Versus Surgical Resection for the Treatment of T1bN0M0 Papillary Thyroid Carcinoma in Different Age Groups
Thyroid
COMMENTED
Related content
Thyroid
A Propensity Score Matching Study Between Microwave Ablation and Radiofrequency Ablation in Terms of Safety and Efficacy for Benign Thyroid Nodules Treatment
Front Endocrinol (Lausanne)
Jin H, Fan J, Lu L, Cui M
doi: 10.3389/fendo.2021.584972
Thyroid
A Novel Scoring System for Predicting the Metastases of Posterior Right Recurrent Laryngeal Nerve Lymph Node Involvement in Patients With Papillary Thyroid Carcinoma by Preoperative Ultrasound
Front Endocrinol (Lausanne)
Lu KN, Zhang Y, Da JY, Zhou TH, Zhao LQ, Peng Y, Pan G, Shi JJ, Zhou L, Ni YQ, Luo DC
doi: 10.3389/fendo.2021.738138
Thyroid
RET, NTRK, ALK, BRAF and MET fusions in a large cohort of pediatric papillary thyroid carcinomas
Thyroid.
Pekova B, Sykorova V, Dvorakova S, Vaclavikova E, Moravcova J, Katra R, Astl J, Vlcek P, Kodetova D, Vcelak J, Bendlova B
doi: 10.1089/thy.2019.0802.
COMMENTED
Thyroid
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
Lancet Diabetes Endocrinol.
Dehbi HM, Mallick U, Wadsley J, Newbold K, Harmer C, Hackshaw A
doi: 10.1016/S2213-
COMMENTED
Thyroid
Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
JAMA.
Mooijaart SP, Du Puy RS, Stott DJ, Kearney PM, Rodondi N, Westendorp RGJ, den Elzen WPJ, Postmus I, Poortvliet RKE, van Heemst D, van Munster BC, Peeters RP, Ford I, Kean S, Messow CM, Blum MR, Collet TH, Watt T, Dekkers OM, Jukema JW, Smit JWA, Langhorne P, Gussekloo J
doi: 10.1001/jama.2019.17274.
Thyroid
Differences in Thyroid Nodule Cytology and Malignancy Risk between Children and Adults
Thyroid.
Cherella CE, Angell TE, Richman DM, Frates MC, Benson CB, Moore FD Jr, Barletta JA, Hollowell M, Smith JR, Alexander EK, Cibas ES, Wassner AJ
doi: 10.1089/thy.2018.0728.
COMMENTED
Thyroid
Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Front Endocrinol (Lausanne)
Czarniecka A, Zeman M, Wozniak G, Maciejewski A, Stobiecka E, Chmielik E, Oczko-Wojciechowska M, Krajewska J, Handkiewicz-Junak D, Jarzab B
doi: 10.3389/fendo.2021.718833
Thyroid
Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer
Thyroid
van Velsen EFS, Visser WE, Stegenga MT, Maeder U, Reiners C, van Kemenade FJ, van Ginhoven TM, Verburg FA, Peeters RP
doi: 10.1089/thy.2020.0615
COMMENTED
Thyroid
The Lenvatinib/Pembrolizumab combination is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Thyroid
Dierks C, Seufert J, Aumann K, Ruf J, Klein C, Kiefer S, Rassner M, Boerries M, Zielke A, La Rosée P, Meyer PT, Kroiss M, Weissenberger C, Schumacher T, Metzger P, Weiss H, Smaxwil C, Laubner K, Duyster J, Bubnoff N, Miething C, Thomusch O
doi: 10.1089/thy.2020.0322